In various diabetic rodent models, berberine has demonstrated numerous pharmacological effects, including reducing total cholesterol, LDL cholesterol, triglyceride levels, and body weight, as well as improving glucose tolerance and enhancing the expression of LDL and insulin receptor (Insr) genes (Day et al., 2017). This evidence concerns the gene INSR and glucose measurement.